BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32561947)

  • 1. The dopamine depleting agent tetrabenazine alters effort-related decision making as assessed by mouse touchscreen procedures.
    Yang JH; Presby RE; Rotolo RA; Quiles T; Okifo K; Zorda E; Fitch RH; Correa M; Salamone JD
    Psychopharmacology (Berl); 2020 Sep; 237(9):2845-2854. PubMed ID: 32561947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological studies of effort-related decision making using mouse touchscreen procedures: effects of dopamine antagonism do not resemble reinforcer devaluation by removal of food restriction.
    Yang JH; Presby RE; Jarvie AA; Rotolo RA; Fitch RH; Correa M; Salamone JD
    Psychopharmacology (Berl); 2020 Jan; 237(1):33-43. PubMed ID: 31392358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.
    Nunes EJ; Randall PA; Hart EE; Freeland C; Yohn SE; Baqi Y; Müller CE; López-Cruz L; Correa M; Salamone JD
    J Neurosci; 2013 Dec; 33(49):19120-30. PubMed ID: 24305809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.
    Yohn SE; Collins SL; Contreras-Mora HM; Errante EL; Rowland MA; Correa M; Salamone JD
    Neuropsychopharmacology; 2016 Feb; 41(3):686-94. PubMed ID: 26105139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of sucrose concentration depends on the effort required to obtain it: studies using tetrabenazine, D1, D2, and D3 receptor antagonists.
    Pardo M; López-Cruz L; San Miguel N; Salamone JD; Correa M
    Psychopharmacology (Berl); 2015 Jul; 232(13):2377-91. PubMed ID: 25647696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding.
    Rotolo RA; Kalaba P; Dragacevic V; Presby RE; Neri J; Robertson E; Yang JH; Correa M; Bakulev V; Volkova NN; Pifl C; Lubec G; Salamone JD
    Psychopharmacology (Berl); 2020 Nov; 237(11):3459-3470. PubMed ID: 32770257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of dopamine D1 receptor transmission in effort-related choice behavior: Effects of D1 agonists.
    Yohn SE; Santerre JL; Nunes EJ; Kozak R; Podurgiel SJ; Correa M; Salamone JD
    Pharmacol Biochem Behav; 2015 Aug; 135():217-26. PubMed ID: 26022661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions related to psychopathology.
    Rotolo RA; Presby RE; Tracy O; Asar S; Yang JH; Correa M; Murray F; Salamone JD
    Neuropharmacology; 2021 Feb; 183():108325. PubMed ID: 32956676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine depletion shifts behavior from activity based reinforcers to more sedentary ones and adenosine receptor antagonism reverses that shift: Relation to ventral striatum DARPP32 phosphorylation patterns.
    López-Cruz L; San Miguel N; Carratalá-Ros C; Monferrer L; Salamone JD; Correa M
    Neuropharmacology; 2018 Aug; 138():349-359. PubMed ID: 29408363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs.
    Randall PA; Lee CA; Nunes EJ; Yohn SE; Nowak V; Khan B; Shah P; Pandit S; Vemuri VK; Makriyannis A; Baqi Y; Müller CE; Correa M; Salamone JD
    PLoS One; 2014; 9(6):e99320. PubMed ID: 24937131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of uptake for dopamine, but not norepinephrine or 5-HT, increases selection of high effort instrumental activity: Implications for treatment of effort-related motivational symptoms in psychopathology.
    Yohn SE; Errante EE; Rosenbloom-Snow A; Somerville M; Rowland M; Tokarski K; Zafar N; Correa M; Salamone JD
    Neuropharmacology; 2016 Oct; 109():270-280. PubMed ID: 27329556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the dopamine depleting agent tetrabenazine on detailed temporal parameters of effort-related choice responding.
    Ren N; Carratala-Ros C; Ecevitoglu A; Rotolo RA; Edelstein GA; Presby RE; Stevenson IH; Chrobak JJ; Salamone JD
    J Exp Anal Behav; 2022 May; 117(3):331-345. PubMed ID: 35344599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms.
    Randall PA; Lee CA; Podurgiel SJ; Hart E; Yohn SE; Jones M; Rowland M; López-Cruz L; Correa M; Salamone JD
    Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25575584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial reversal of the effort-related motivational effects of tetrabenazine with the MAO-B inhibitor deprenyl (selegiline): Implications for treating motivational dysfunctions.
    Contreras-Mora H; Rowland MA; Yohn SE; Correa M; Salamone JD
    Pharmacol Biochem Behav; 2018 Mar; 166():13-20. PubMed ID: 29309800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors.
    Farrar AM; Segovia KN; Randall PA; Nunes EJ; Collins LE; Stopper CM; Port RG; Hockemeyer J; Müller CE; Correa M; Salamone JD
    Neuroscience; 2010 Apr; 166(4):1056-67. PubMed ID: 20096336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacology of effort-related choice behavior: Dopamine, depression, and individual differences.
    Salamone JD; Correa M; Yohn S; Lopez Cruz L; San Miguel N; Alatorre L
    Behav Processes; 2016 Jun; 127():3-17. PubMed ID: 26899746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion.
    Yohn SE; Thompson C; Randall PA; Lee CA; Müller CE; Baqi Y; Correa M; Salamone JD
    Psychopharmacology (Berl); 2015 Apr; 232(7):1313-23. PubMed ID: 25323625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleus accumbens neurotransmission and effort-related choice behavior in food motivation: effects of drugs acting on dopamine, adenosine, and muscarinic acetylcholine receptors.
    Nunes EJ; Randall PA; Podurgiel S; Correa M; Salamone JD
    Neurosci Biobehav Rev; 2013 Nov; 37(9 Pt A):2015-25. PubMed ID: 23583616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation and optimisation of a touchscreen progressive ratio test of motivation in male rats.
    Hailwood JM; Heath CJ; Robbins TW; Saksida LM; Bussey TJ
    Psychopharmacology (Berl); 2018 Sep; 235(9):2739-2753. PubMed ID: 30008032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing.
    Farrar AM; Pereira M; Velasco F; Hockemeyer J; Müller CE; Salamone JD
    Psychopharmacology (Berl); 2007 Apr; 191(3):579-86. PubMed ID: 17072593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.